Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · IEX Real-Time Price · USD
39.78
+0.91 (2.34%)
At close: Jul 19, 2024, 4:00 PM
40.45
+0.67 (1.68%)
Pre-market: Jul 22, 2024, 7:23 AM EDT

Immunocore Holdings Statistics

Total Valuation

IMCR has a market cap or net worth of $1.99 billion. The enterprise value is $1.52 billion.

Market Cap 1.99B
Enterprise Value 1.52B

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date Aug 8, 2024
Ex-Dividend Date n/a

Share Statistics

IMCR has 50.01 million shares outstanding.

Shares Outstanding 50.01M
Owned by Insiders (%) 5.29%
Owned by Institutions (%) 87.20%
Float 40.19M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.53
Forward PS 6.26
PB Ratio 4.28
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.77
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.96, with a Debt / Equity ratio of 1.31.

Current Ratio 5.96
Quick Ratio 5.73
Debt / Equity 1.31
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7.90

Financial Efficiency

Return on equity (ROE) is -16.40% and return on invested capital (ROIC) is -7.74%.

Return on Equity (ROE) -16.40%
Return on Assets (ROA) -8.60%
Return on Capital (ROIC) -7.74%
Revenue Per Employee $531,698
Profits Per Employee -$118,414
Employee Count 497
Asset Turnover 0.39
Inventory Turnover 0.40

Taxes

Income Tax -7.16M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.52% in the last 52 weeks. The beta is 0.75, so IMCR's price volatility has been lower than the market average.

Beta (5Y) 0.75
52-Week Price Change -37.52%
50-Day Moving Average 43.18
200-Day Moving Average 55.81
Relative Strength Index (RSI) 50.97
Average Volume (20 Days) 513,739

Short Selling Information

Short Interest 5.87M
Short Previous Month 6.21M
Short % of Shares Out 13.39%
Short % of Float n/a
Short Ratio (days to cover) 5.86

Income Statement

In the last 12 months, IMCR had revenue of $264.25 million and -$58.85 million in losses. Loss per share was -$1.54.

Revenue 264.25M
Gross Profit 339.87M
Operating Income -83.17M
Pretax Income -83.15M
Net Income -58.85M
EBITDA -66.61M
EBIT -73.81M
Loss Per Share -$1.54
Full Income Statement

Balance Sheet

The company has $1.08 billion in cash and $610.51 million in debt, giving a net cash position of $464.94 million or $9.30 per share.

Cash & Cash Equivalents 1.08B
Total Debt 610.51M
Net Cash 464.94M
Net Cash Per Share $9.30
Equity (Book Value) 464.28M
Book Value Per Share 9.28
Working Capital 995.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$617,583 and capital expenditures -$3.57 million, giving a free cash flow of -$4.19 million.

Operating Cash Flow -617,583
Capital Expenditures -3.57M
Free Cash Flow -4.19M
FCF Per Share -$0.08
Full Cash Flow Statement

Margins

Gross margin is 128.62%, with operating and profit margins of -31.47% and -22.27%.

Gross Margin 128.62%
Operating Margin -31.47%
Pretax Margin -31.47%
Profit Margin -22.27%
EBITDA Margin -25.21%
EBIT Margin -27.93%
FCF Margin -1.59%

Dividends & Yields

IMCR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.51%
Shareholder Yield -3.51%
Earnings Yield -2.96%
FCF Yield -0.21%
Dividend Details

Analyst Forecast

The average price target for IMCR is $82.75, which is 108.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target $82.75
Price Target Difference 108.02%
Analyst Consensus Strong Buy
Analyst Count 13
Revenue Growth Forecast (5Y) 17.50%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

IMCR has an Altman Z-Score of 1.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.32
Piotroski F-Score 3